Sarah Collins
Nurse Practitioner · Southfield, MINPI 1548514177
Payments from drug & device makers
Across 223 payments — averaging $18.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$412
- Lilly USA, LLC$403
- AbbVie$402
- AstraZeneca$349
- Otsuka America Pharmaceutical, Inc.$295
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$295
- plus $2K from 29 others
What the payments were for
- Food & beverage$4,193100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 25 | $412 |
| Lilly USA, LLC | 24 | $403 |
| AbbVie | 23 | $402 |
| AstraZeneca | 20 | $349 |
| Otsuka America Pharmaceutical, Inc. | 18 | $295 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 15 | $295 |
| Pfizer | 13 | $291 |
| Biohaven Pharmaceuticals, Inc. | 4 | $180 |
| Axsome Therapeutics, Inc. | 7 | $175 |
| Boehringer Ingelheim | 11 | $174 |
| Biohaven Pharmaceutical Holding Company Ltd. | 6 | $129 |
| Lundbeck LLC | 7 | $125 |
| GSK | 5 | $111 |
| Indivior Inc. | 5 | $100 |
| Exact Sciences | 6 | $88 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $79 |
| Regeneron Healthcare Solutions, Inc. | 4 | $75 |
| Mylan Specialty L.p. | 3 | $72 |
| Alkermes, Inc. | 2 | $58 |
| E.r. Squibb & Sons, L.L.C. | 2 | $54 |
| Corcept Therapeutics | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Insulet Corporation | 2 | $31 |
| Surgenex LLC | 1 | $27 |
| Viatris Specialty LLC | 1 | $23 |
| Hologic Sales And Service, LLC | 1 | $21 |
| Sanofi Pasteur Inc. | 1 | $20 |
| Bayer | 1 | $19 |
| Sunovion Pharmaceuticals Inc. | 1 | $19 |
| Novartis | 1 | $19 |
| Amgen | 1 | $18 |
| Eisai Inc. | 1 | $16 |
| Merck | 1 | $15 |
| Gilead | 1 | $14 |
| Inari Medical, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$125
How this compares
$4,193 in reported general payments places this provider in the 95th percentile of 3,351 nurse practitioner providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 134 | $121,583 |
| TrulicityDulaglutide | 101 | $94,867 |
| OzempicSemaglutide | 62 | $75,175 |
| RexultiBrexpiprazole | 34 | $58,166 |
| JanuviaSitagliptin Phosphate | 41 | $44,902 |
| FarxigaDapagliflozin Propanediol | 37 | $36,642 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 40 | $26,677 |
| EliquisApixaban | 21 | $19,992 |
| MounjaroTirzepatide | 13 | $15,505 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 12 | $11,249 |
| Advair HfaFluticasone Propion/Salmeterol | 24 | $8,609 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 12 | $7,997 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 16 | $6,973 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 150 | $5,371 |
| MyrbetriqMirabegron | 12 | $4,850 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Combivent Respimat | $174 | $132,832146 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $403 | $110,373114 claims |
| Novo NordiskOzempic | $412 | $75,17562 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $295 | $58,16634 claims |
| MerckJanuvia | $15 | $44,90241 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $349 | $44,63849 claims |
| GSKTrelegy Ellipta | $111 | $26,67740 claims |
| PfizerEliquis | $291 | $19,99221 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,351 nurse practitioner providers in Michigan.
Other nurse practitioner in Southfield
- Davida KrugerDetroit$1.8M
- Kari HillSpring Lake$426K
- Kyle FarrPlymouth$243K
- Linda SpencerTroy$217K
- Ellen DillardDetroit$168K
- Golbon AghamohammadiDetroit$157K
- Abubakir BabanDearborn$143K
- Elizabeth KirshnerAnn Arbor$119K
- Lisa Astalos ChismWoodhaven$103K
- Martha GoetzPetoskey$101K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.